Antiserum against a recombinant soluble form of PilA (rsPilA) inhibits NTHI biofilm formation in vitro (9, 10) and prevents the onset of NTHI-induced OM in a chinchilla model (11). Here, HIVEP2-DT is linked to ocular melanoma.